Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
3
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
cystic fibrosis
deals
gene therapy
investing
nestle
nonalcoholic steatohepatitis
opioid
roche
What
ahead
3
×
roundup
asco
bio
cancer
days
abbvie’s
ambien
american
annual
attendees
attention
biofourmis
biotech
branded
bucks
camp’s
cash
celebrate
chance
chicago
choices
city
clinical
combinations
commissioner
community’s
consumers
corner
costly
counterweight
day
drug
drugs
elevatebio
expanding
fda
focus
forward
generic
Language
unset
Current search:
ahead
×
photo
×
" raleigh-durham blog main "
×
biotech
×
@xconomy.com
4 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More